CMI Communications

05/06/2026

🎙️ A special bonus episode of is coming Monday

Angela Huttner & Anne-Grete Märtson talk with Daniel Bausch & Martin Grobusch on how ebolavirus differs from Zaire & what to expect in the current outbreak

https://ow.ly/nm5250Z7ViE

31/05/2026

🎙️ Just published Communicable E54: ESCMID Global Late Breakers, part 2

Hosted by our editors - Erin McCreary, Josh Davis, Marc Bonten, Anne-Grete Märtson, Angela Huttner 🌟

Listen on : https://share.transistor.fm/s/a8cc04bb

28/05/2026

📣 New drops Mon, 01 June!

Our editors - Erin McCreary, Josh Davis, Marc Bonten, Anne-Grete Märtson, Angela Huttner - are back for part 2 of this series, discussing 5 more late-breaking trials at , and whether they should change your practice🎙️

26/05/2026

📣 Note to microbiologists & clinicians who need to isolate spp for antibiogram profiling:

Klugherz et al. show that adding to -Lowe agar doubles the rate of isolation in culture



https://www.cmi-comms.org/article/S2950-5909(26)00020-X/

19/05/2026

🗞️ Person behind the name:

Wolbachia are intracellular Gram-negative bacteria that can manipulate their arthropod hosts' reproduction. Discovered by Hertig and Burt Wollbach, Hertig formally named them after his colleague in 1936.

https://www.cmi-comms.org/article/S2950-5909(26)00014-4/

18/05/2026

🎙️ Just published Communicable E53: ESCMID Global Late Breakers, part 1

Hosted by our editors - Erin McCreary, Josh Davis, Marc Bonten, Anne-Grete Märtson, Angela Huttner 🌟

Listen on : https://share.transistor.fm/s/e2f3e270

The ESCMID Global Late Breakers series returns to Communicable! Five CMI Communications editors – Marc Bonten, Josh Davis, Angela Huttner, Anne-Grete Märtson, and Erin McCreary – handpicked five late-breaking trials presented at ESCMID Global 2026 to summarise their findings and discuss whether...

13/05/2026

📣 Migrants & refugees face a higher burden of but lower access to & appropriate use, both difficult to quantify

An international expert team has created AdMiRE, a WHO-aligned tool to assess & compare across populations

https://ow.ly/wrFE50YZ0yG

30/04/2026

📣 New data from the ERADICATE bacteremia trial:

In patients with renal dysfunction, clinical success was similar with vs . Cefto showed no association w/ renal injury relative to dapto.

https://www.cmi-comms.org/article/S2950-5909(26)00012-0/fulltext

28/04/2026

📣Never underestimate . Your patient in a high-income country that you diagnosed with ulcerative colitis may have it instead.

These authors describe a case of in our series led by Emily McDonald

https://ow.ly/nne550YQUrY

27/04/2026

Over on Bluesky, our readers noticed a similarity in names between the subject of this 'Person behind the name' commentary and its last author.

Full (lovely) story: these commentaries are peer-reviewed. First submission authored by Llor & Kjaer. A reviewer suggests they contact Prof Gram (granddaughter of HC Gram). They do. She contributes meaningfully (including his portrait!) & they feel it only right to make her last author.

https://ow.ly/zHZn50YQFmh